$771 Million is the total value of ARCH Venture Management, LLC's 10 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 20.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KRTX | Sell | KARUNA THERAPEUTICS, INC. | $295,304,000 | -19.9% | 1,312,872 | -54.9% | 38.28% | -14.7% |
| EQRX, INC. | $179,860,000 | +5.5% | 36,335,375 | 0.0% | 23.32% | +12.3% | ||
| DNLI | Sell | DENALI THERAPEUTICS, INC. | $112,594,000 | -26.0% | 3,668,749 | -29.0% | 14.60% | -21.3% |
| ERASCA, INC. | $86,233,000 | +40.0% | 11,055,554 | 0.0% | 11.18% | +49.0% | ||
| VERV | Sell | VERVE THERAPEUTICS, INC. | $69,003,000 | +80.0% | 2,008,809 | -19.9% | 8.94% | +91.5% |
| REVH | REVOLUTION HEALTHCARE ACQUISITION CORP. | $13,342,000 | +0.6% | 1,357,237 | 0.0% | 1.73% | +7.1% | |
| OMIC | SINGULAR GENOMICS SYSTEMS, INC. | $9,497,000 | -34.6% | 3,798,926 | 0.0% | 1.23% | -30.4% | |
| New | UNITY BIOTECHNOLOGY, INC. | $3,970,000 | – | 10,048,181 | +100.0% | 0.52% | – | |
| MTCR | METACRINE, INC. | $1,426,000 | -3.0% | 2,940,503 | 0.0% | 0.18% | +3.4% | |
| RUBY | RUBIUS THERAPEUTICS, INC. | $152,000 | -49.0% | 349,908 | 0.0% | 0.02% | -44.4% | |
| ZY | Exit | ZYMERGEN INC. | $0 | – | -119,205 | -100.0% | -0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| RUBIUS THERAPEUTICS, INC. | 12 | Q3 2022 | 65.5% |
| EQRX, INC. | 8 | Q3 2023 | 52.4% |
| ERASCA, INC. | 8 | Q3 2023 | 18.8% |
| VERVE THERAPEUTICS, INC. | 8 | Q3 2023 | 23.3% |
| CHIASMA INC | 8 | Q3 2020 | 25.7% |
| SINGULAR GENOMICS SYSTEMS, INC. | 8 | Q3 2023 | 4.6% |
| KURA ONCOLOGY INC | 7 | Q2 2020 | 27.6% |
| KARUNA THERAPEUTICS, INC. | 6 | Q1 2023 | 52.8% |
| DENALI THERAPEUTICS, INC. | 6 | Q3 2023 | 28.6% |
| SYROS PHARMACEUTICALS INC | 5 | Q3 2020 | 43.8% |
View ARCH Venture Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-15 |
| 13F-HR/A | 2022-05-27 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
View ARCH Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.